In today’s briefing:
- Both Statutory Nomination Committee and BODs Chaired by Outside Directors Are in the 2% Range
Both Statutory Nomination Committee and BODs Chaired by Outside Directors Are in the 2% Range
- Since the number of companies transitioning to US Type 3 Committees isn’t increasing, a perverse debate has begun on weakening the authority of nomination committees in US Type 3 Committees.
- Despite calls from investors to appoint outside directors as chairpersons of BODs to stimulate discussion and strengthen supervisory functions by separating supervision from execution, these calls have been ignored.
- If the board of directors simply approves plans created by each business division based on their budgets, then it is not involved in important company decisions.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
